The Motley Fool’s experts weigh in on payer pushback to new cholesterol busting medicine and surging Obamacare penalties in 2016.
The Motley Fool’s experts weigh in on payer pushback to new cholesterol busting medicine and surging Obamacare penalties in 2016.